TH sample ID	Diagnosis	At least one DNA target aberrantly expressed?	Utility of RNA sequencing	Solid/leukemia	DNA mutation call of clinical relevance	DNA mutation category NCI Pediatric MATCH	Treehouse category	Outlier confirmed by pathway	Outlier not confirmed by pathway	gene	mutation	note/	testVendor	status
TH01_0123_S01	acute lymphoblastic leukemia	Yes	Prioritizing among multiple DNA findings	leukemia						new sample				
					FLT3 amplification	Receptor Tyrosine Kinase (RTK)	Receptor Tyrosine Kinase (RTK)	FLT3, FLT4		FLT3	Low-levelAmplification		NantOmics	
					JAK2 p.R683S	JAK/STAT	JAK/STAT	JAK3		JAK2	p.R683S		NantOmics	
							B-cell receptor signaling	MS4A1		JAK2	p.R683S		NantOmics	
							PI3K/AKT/mTOR	PIK3CD, PIK3CG, RPTOR						
TH01_0132_S01	acute myeloid leukemia	RNA only target	RNA only target	leukemia										
					No druggable mutations		B-cell reseptor signaling	BTK		MLLT10-KMT2A	MLL rearrangement		NantOmics	
							Cell cycle	CDK6						
							PI3K/AKT/mTOR	PIK3CG						
TH01_0129_S01	acute lymphoblastic leukemia	No	Additional expression support for DNA finding	leukemia										
					BCR-ABL1 fusion	Other								
							B-cell reseptor signaling	MS4A1		BCR-ABL1			NantOmics	
							PI3K/AKT/mTOR	PIK3CG						
TH01_0120_S01	acute myeloid leukemia	RNA only target	RNA only target	leukemia										
					No druggable mutations		Cell cycle	CDK6		GATA2	p.L321F			
							Receptor Tyrosine Kinase (RTK)	KIT						
TH01_0121_S01	acute lymphoblastic leukemia	RNA only target	RNA only target	leukemia										
					No druggable mutations		JAK/STAT	IL6R, JAK3, STAT5B						
							B-cell receptor signaling	MS4A1						
							PI3K/AKT/mTOR	PIK3CD, PIK3CG, PIK3R5						
TH01_0122_S01	acute lymphoblastic leukemia	No	Additional expression support for DNA finding	leukemia										
					PAX5-JAK2 fusion	JAK/STAT				PAX5-JAK2				
							B-cell receptor signaling	MS4A1						
							PI3K/AKT/mTOR	PIK3CD, PIK3CG						
TH01_0124_S01	acute lymphoblastic leukemia	No		leukemia										
					KRAS p.G13D, NRAS p.G12D	RAS/RAF/MEK				KRAS	p.G13D			
							Receptor Tyrosine Kinase (RTK)	FLT3		NRAS	p.G12D			
TH01_0125_S01	acute lymphoblastic leukemia	RNA only target	RNA only target	leukemia										
					No druggable mutations		Receptor Tyrosine Kinase (RTK)	FLT3		CSF3R	p.D320N			
										KMT2A-AFF1				
							PI3K/AKT/mTOR	PIK3CG		TSC2	p. R367Q	TSC2 mutation benign in HGMD		
							Cell cycle	CDK6						
							B-cell receptor signaling	BTK						
TH01_0126_S01	acute lymphoblastic leukemia	DNA only target	DNA only target	leukemia										
					NRAS p.G12D	RAS/RAF/MEK	No automated leads			NRAS	p.G12D			
					CDKN2A deletion	Cell Cycle				CDKN2A	deletion			
TH01_0128_S01	acute lymphoblastic leukemia	RNA only target	RNA only target	leukemia										
					No druggable mutations		JAK/STAT	IL6R						
							PI3K/AKT/mTOR	PIK3CD, PIK3CG, PIK3R5						
TH01_0134_S01	acute lymphoblastic leukemia	No	Additional expression support for DNA finding	leukemia										
					NRAS p.G13D	RAS/RAF/MEK				NRAS	p. G13D			
							Cell cycle	CDK6						
TH01_0133_S01	acute lymphoblastic leukemia	RNA only target	RNA only target	leukemia										
					No druggable mutations		Receptor Tyrosine Kinase (RTK)		FLT3					
TH01_0131_S01	acute lymphoblastic leukemia	No	DNA finding likely a technical artifact	leukemia										
					JAK2 p.R683S	JAK/STAT				JAK2	p.R683S			
							B-cell receptor signaling	BTK						
							Cell cycle	CDK6						
							Receptor Tyrosine Kinase (RTK)	FLT3, FLT4						
							PI3K/AKT/mTOR	PIK3CG						
TH01_0127_S01	acute lymphoblastic leukemia	Yes	Prioritizing among multiple DNA findings	leukemia										
					FLT3 p.V592D	Receptor Tyrosine Kinase (RTK)	Receptor Tyrosine Kinase (RTK)	FLT3		FLT3	p.V592D			
					KRAS p.G12D	RAS/RAF/MEK				KRAS	p.G12D			
							B-cell receptor signaling	BTK						
							PI3K/AKT/mTOR	PIK3CG						
TH01_0130_S01	acute lymphoblastic leukemia	No	Additional expression support for DNA finding	leukemia										
					PAX5-JAK2 fusion	JAK/STAT								
							Receptor Tyrosine Kinase (RTK)	FLT3						
							B-cell receptor signaling	MS4A1						
							PI3K/AKT/mTOR	PIK3CG						
TH02_0082_S01	diffuse intrinsic pontine glioma	No DNA or RNA targets	No DNA or RNA targets	solid						new sample				
					No druggable mutations		No automated leads			H3F3A	Missense Nonsense or Frameshift		TGen	
TH02_0083_S01	diffuse intrinsic pontine glioma	Yes	Prioritizing among multiple DNA findings	solid						new sample				
										CRKL	Gain		TGen	
										H3F3A	Missense Nonsense or Frameshift		TGen	
					KDR gain	Receptor Tyrosine Kinase (RTK)				KDR	Gain		TGen	
					KIT gain	Receptor Tyrosine Kinase (RTK)				KIT	Gain		TGen	
										MAPK1	Gain		TGen	
					MET gain	Receptor Tyrosine Kinase (RTK)				MET	Gain		TGen	
					PDGFRA gain	Receptor Tyrosine Kinase (RTK)	Receptor Tyrosine Kinase (RTK)	PDGFRA		PDGFRA	Gain		TGen	
										TP53	Missense Nonsense or Frameshift		TGen	
TH02_0084_S01	diffuse intrinsic pontine glioma	No DNA or RNA targets	No DNA or RNA targets	solid						new sample				
					No druggable mutations		No automated leads			TP53	Missense Nonsense or Frameshift		TGen	
TH02_0085_S01	diffuse intrinsic pontine glioma	Yes	Prioritizing among multiple DNA findings	solid						new sample				
										H3F3A	Missense Nonsense or Frameshift		TGen	
					KDR gain	Receptor Tyrosine Kinase (RTK)				KDR	Gain		TGen	
					KIT gain	Receptor Tyrosine Kinase (RTK)				KIT	Gain		TGen	
					PDGFRA gain	Receptor Tyrosine Kinase (RTK)	Receptor Tyrosine Kinase (RTK)		PDGFRA	PDGFRA	Gain		TGen	
										TP53	Missense Nonsense or Frameshift		TGen	
TH02_0086_S01	diffuse intrinsic pontine glioma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		Sonic Hedgehog (SHH)		PTCH1	ATRX	Missense Nonsense or Frameshift		TGen	
										H3F3A	Missense Nonsense or Frameshift		TGen	
										PPM1D	Missense Nonsense or Frameshift		TGen	
TH02_0087_S01	diffuse intrinsic pontine glioma	No		solid						new sample				
										H3F3A	Missense Nonsense or Frameshift		TGen	
										H3F3A	p.K27M		TGen	
					PIK3R1 unspecified aberration, called druggable by clinical testing lab	PI3K/AKT/mTOR				PIK3R1	Missense Nonsense or Frameshift		TGen	
										PPM1D	Missense Nonsense or Frameshift		TGen	
							JAK/STAT	JAK1		TP53	Missense Nonsense or Frameshift		TGen	
										TP53	p.R282W		TGen	
TH02_0087_S02	diffuse intrinsic pontine glioma	DNA only target	DNA only target	solid						new sample				
										H3F3A	p.K27M		TGen	
					PIK3R1 unspecified aberration, called druggable by clinical testing lab	PI3K/AKT/mTOR	No automated leads			PIK3R1	Unspecified		TGen	
										PPM1D	Unspecified		TGen	
TH02_0088_S01	diffuse intrinsic pontine glioma	No DNA or RNA targets	No DNA or RNA targets	solid						new sample				
					No druggable mutations		No automated leads			ATRX	Deletion			
										H3F3A	Missense Nonsense or Frameshift			
										TP53	Missense Nonsense or Frameshift			
TH02_0089_S01	diffuse intrinsic pontine glioma	No DNA or RNA targets	No DNA or RNA targets	solid						new sample				
					No druggable mutations		No automated leads			ATRX	Missense Nonsense or Frameshift		TGen 	
										H3F3A	Missense Nonsense or Frameshift		TGen 	
										TP53	Missense Nonsense or Frameshift		TGen 	
TH02_0090_S01	diffuse intrinsic pontine glioma	Yes	Additional expression support for DNA finding	solid						new sample				
							Sonic Hedgehog (SHH)		PTCH1					
										ATRX	Missense Nonsense or Frameshift		TGen 	
					IGF1R gain	Receptor Tyrosine Kinase (RTK)				IGF1R	Gain		TGen 	
										TP53	Missense Nonsense or Frameshift		TGen 	
TH02_0091_S01	diffuse intrinsic pontine glioma	No		solid						new sample				
							Receptor Tyrosine Kinase (RTK)	CSF1R						
					BRAF p.V600E	RAS/RAF/MEK				BRAF p.V600E	Missense Nonsense or Frameshift		TGen 	
										H3F3A	Missense Nonsense or Frameshift		TGen 	
TH02_0092_S01	diffuse intrinsic pontine glioma	No	Additional expression support for DNA finding	solid						new sample				
										ATRX	Missense Nonsense or Frameshift		TGen 	
							RAS/RAF/MEK	MEK1		H3F3A	Missense Nonsense or Frameshift		TGen 	
					KDR gain	Receptor Tyrosine Kinase (RTK)				KDR	Gain		TGen 	
					KIT gain	Receptor Tyrosine Kinase (RTK)				KIT	Gain		TGen 	
					PDGFRA gain	Receptor Tyrosine Kinase (RTK)				PDGFRA	Gain		TGen 	
										PTEN	Deletion		TGen 	
										TP53	Missense Nonsense or Frameshift		TGen 	
TH02_0093_S01	diffuse intrinsic pontine glioma	DNA only target	DNA only target	solid						new sample				
							No automated leads			H3F3A	Missense Nonsense or Frameshift		TGen 	
					MET gain	Receptor Tyrosine Kinase (RTK)				MET	Gain		TGen 	
					PDGFRA gain	Receptor Tyrosine Kinase (RTK)				PDGFRA	Gain		TGen 	
										TP53	Missense Nonsense or Frameshift		TGen 	
TH02_0094_S01	diffuse intrinsic pontine glioma	Yes	Additional expression support for DNA finding	solid						new sample				
										H3F3A	Missense Nonsense or Frameshift		TGen 	
					MET gain	Receptor Tyrosine Kinase (RTK)	Receptor Tyrosine Kinase (RTK)		MET	MET	Gain		TGen 	
										TP53	Missense Nonsense or Frameshift		TGen 	
TH02_0095_S01	diffuse intrinsic pontine glioma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		Sonic Hedgehog (SHH)		PTCH1	ACVR1	p.R206H		TGen 	
										HIST1H3B	p.K27M		TGen 	
										TP53	p.R248Q		TGen 	
TH02_0096_S01	diffuse intrinsic pontine glioma	No DNA or RNA targets	No DNA or RNA targets	solid						new sample				
					No druggable mutations		No automated leads			AHNAK	del		TGen 	
										AKT1	del		TGen 	
										AURKB1	del		TGen 	
										H3F3A	p.K27M		TGen 	
										H3F3B	del		TGen 	
										TP53	del		TGen 	
										TP53BP1	del		TGen 	
TH03_0003_S01	sarcoma	DNA only target	DNA only target	solid						new sample				
							No automated leads			ATRX	LossExons13-35		Foundation Medicine	
					CDKN2A/2B deletion	Cell Cycle				CDKN2A	CDKN2A_loss		Foundation Medicine	
										CDKN2B	CDKN2B_loss		Foundation Medicine	
										TP53	TruncationExon9		Foundation Medicine	
TH03_0003_S03	sarcoma	DNA only target	DNA only target	solid						new sample				
							No automated leads			ATRX	LossExons13-35		Foundation Medicine	
					CDKN2A/2B deletion	Cell Cycle				CDKN2A	CDKN2A_loss		Foundation Medicine	
										CDKN2B	CDKN2B_loss		Foundation Medicine	
										TP53	TruncationExon9		Foundation Medicine	
TH03_0003_S04	sarcoma	DNA only target	DNA only target	solid						new sample				
							No automated leads			ATRX	LossExons13-35		Foundation Medicine	
					CDKN2A/2B deletion	Cell Cycle				CDKN2A	CDKN2A_loss		Foundation Medicine	
										CDKN2B	CDKN2B_loss		Foundation Medicine	
										TP53	TruncationExon9		Foundation Medicine	
TH03_0004_S02	hepatoblastoma	No DNA or RNA targets	No DNA or RNA targets	solid						new sample				
					No druggable mutations		No automated leads			CTNNB1	p.G34V		Foundation Medicine	
										CTNNB1	p.G34V		Foundation Medicine	
TH03_0004_S03	hepatoblastoma	No DNA or RNA targets	No DNA or RNA targets	solid						new sample				
					No druggable mutations		No automated leads			CTNNB1	p.G34V		Foundation Medicine	
										CTNNB1	p.G34V		Foundation Medicine	
TH03_0004_S04	hepatoblastoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		JAK/STAT	IL6		CTNNB1	p.G34V		Foundation Medicine	
							Heat Shock Proteins	HSP90B1		CTNNB1	p.G34V		Foundation Medicine	
TH03_0005_S01	nasopharyngeal carcinoma	No DNA or RNA targets	No DNA or RNA targets	solid						new sample				
					No druggable mutations		No automated leads			CTNNB1	DuplicationExons9-13		Foundation Medicine	
										CTNNB1	DuplicationExons9-13		Foundation Medicine	
										TP53	p.S241F		Foundation Medicine	
										TP53	p.S241F		Foundation Medicine	
TH03_0006_S01	rhabdomyosarcoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		Heat Shock Proteins		HSP90B1	BRD4	RearrangementExon6		Foundation Medicine	
										CREBBP	s894fs*64		Foundation Medicine	
										IKZF2	DeletionExon 4		Foundation Medicine	
										MYC	Amplification(Equivocal)		Foundation Medicine	
										TP53	p.R282W		Foundation Medicine	
TH03_0006_S03	rhabdomyosarcoma	No DNA or RNA targets	No DNA or RNA targets	solid						new sample				
					No druggable mutations		No automated leads			BRD4	RearrangementExon6		Foundation Medicine	
										CREBBP	s894fs*64		Foundation Medicine	
										IKZF2	DeletionExon 4		Foundation Medicine	
										MYC	Amplification(Equivocal)		Foundation Medicine	
										TP53	p.R282W		Foundation Medicine	
TH03_0008_S01	neuroblastoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		PI3K/AKT/mTOR	RPTOR		ATRX	LossExons2-9		Foundation Medicine	
							JAK/STAT	STAT5		CIC	p.R215W		Foundation Medicine	
										MYC	SingleCopy		Foundation Medicine	
TH03_0010_S01	acute leukemia of ambiguous lineage, CNS1	No	Additional expression support for DNA finding	leukemia						new sample				
							B-cell receptor signaling	BTK		CREBBP	SpliceSite5173-1G>A		Foundation Medicine	
							Cell cycle	CDK6						
							JAK/STAT	STAT5A		JAK3	p.A573T		Foundation Medicine	
					NRAS p.Q61H	RAS/RAF/MEK				NRAS	p.Q61H		Foundation Medicine	
										TP53	p.C135F		Foundation Medicine	
TH03_0010_S02	acute leukemia of ambiguous lineage, CNS1	No	Additional expression support for DNA finding	leukemia						new sample				
							B-cell receptor signaling	BTK		CREBBP	SpliceSite5173-1G>A		Foundation Medicine	
							BCL2/MDM2	MDM2		JAK3	p.A573T		Foundation Medicine	
							JAK/STAT	STAT5A						
					NRAS p.Q61H	RAS/RAF/MEK				NRAS	p.Q61H		Foundation Medicine	
										TP53	p.C135F		Foundation Medicine	
TH03_0011_S01	acute lymphoblastic leukemia	No	Additional expression support for DNA finding	leukemia						new sample				
							B-cell receptor signaling	BTK		BCOR	p.C1572F		Foundation Medicine	
							Cell cycle	CCND3		BCOR	p.C1572F		Foundation Medicine	
							Receptor Tyrosine Kinase (RTK)	FLT3		CPS1	p.K1281		Foundation Medicine	
							JAK/STAT	IL6R		EXOSC6	p.G10C		Foundation Medicine	
										EXOSC6	p.G10C		Foundation Medicine	
										MAP3K1	p.S939C		Foundation Medicine	
										MAP3K1	p.S939C		Foundation Medicine	
										MLL2	p.V4305I		Foundation Medicine	
										MLL2	p.V4305I		Foundation Medicine	
										MLL3	p.G1582V		Foundation Medicine	
										MLL3	p.G1582V		Foundation Medicine	
										MLL3	p.L804V		Foundation Medicine	
										NCOR2	p.K1405R		Foundation Medicine	
										NOTCH1	p.T859M		Foundation Medicine	
					NRAS p.Q61K	RAS/RAF/MEK				NRAS	p.Q61K		Foundation Medicine	
										NTRK1	p.R744H		Foundation Medicine	
										PCLO	p.S4289_S4292del		Foundation Medicine	
TH03_0012_S01	wilms tumor	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		PI3K/AKT/mTOR		PIK3R1	ABL2	p.T671M		Foundation Medicine	
										ALK	p.E1435K		Foundation Medicine	
										AR	p.G457_G468del		Foundation Medicine	
										ASXL1	p.G645fs*58		Foundation Medicine	
										SPEN	p.S2306del		Foundation Medicine	
										TP53	p.C176S		Foundation Medicine	
TH03_0012_S02	wilms tumor	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		JAK/STAT	STAT3		ABL2	p.T671M		Foundation Medicine	
										ALK	p.E1435K		Foundation Medicine	
										AR	p.G457_G468del		Foundation Medicine	
										ASXL1	p.G645fs*58		Foundation Medicine	
										SPEN	p.S2306del		Foundation Medicine	
										TP53	p.C176S		Foundation Medicine	
TH03_0016_S01	atypical teratoid/rhabdoid tumor	No	Additional expression support for DNA finding	solid						new sample				
							Receptor Tyrosine Kinase (RTK)	ERBB2		SMARCB1	p.P383fs*4+		Foundation Medicine	
							Receptor Tyrosine Kinase (RTK)	FGFR1						
							JAK/STAT	IL6						
					SMARCB1 p.P383fs*4+	Chromatin remodeling								
TH03_0019_S01	fibrolamellar hepatocellular carcinoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations					FANCG	p.A607T		Foundation Medicine	
							Receptor Tyrosine Kinase (RTK)	FLT1						
							Receptor Tyrosine Kinase (RTK)	KDR						
TH03_0114_S01	fibrolamellar hepatocellular carcinoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		No automated leads			MLL3	p.C310S		Foundation Medicine	
										TERT	promoter 124C>T		Foundation Medicine	
TH03_0143_S01	osteosarcoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		JAK/STAT	IL6		FANCL	p.S351fs*2		Foundation Medicine	
										MLL3	p.Y306*		Foundation Medicine	
TH03_0143_S02	osteosarcoma	No DNA or RNA targets	No DNA or RNA targets	solid										
					No druggable mutations		No automated leads			FANCL	p.S351fs*2		Foundation Medicine	
										MLL3	p.Y306*		Foundation Medicine	
TH03_0149_S01	acute myeloid leukemia	Yes	Additional expression support for DNA finding	leukemia						new sample				
					FLT3-ITD	Receptor Tyrosine Kinase (RTK)	Receptor Tyrosine Kinase (RTK)	FLT3		FLT3	FLT3-ITD Y597-E598ins15		Foundation Medicine	
							B-cell receptor signaling	BTK		WT1	p.S381fs*67		Foundation Medicine	
TH03_0286_S01	hepatocellular carcinoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		Receptor Tyrosine Kinase (RTK)	PDGFRB		CTNNB1	SpliceSite14-59_241+79del366		Foundation Medicine	
TH03_0288_S01	neuroblastoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		Cell cycle	CDK6		ATRX	LossExons2-12		Foundation Medicine	
TH03_0290_S01	glioma	No	No expression evidence for DNA target	solid						new sample				
					BRAF p.V600E	RAS/RAF/MEK				BRAF	p.V600E		Foundation Medicine	
							JAK/STAT	IL6		CDKN2A	CDKN2A/B Loss		Foundation Medicine	
TH03_0013_S02	acute lymphoblastic leukemia	RNA only target	RNA only target	leukemia						new sample				
					No druggable mutations		Cell cycle	CDK6		t(14;19)	translocation		chromosomal analysis	
							PI3K/AKT/mTOR	PIK3CD						
							PI3K/AKT/mTOR	PIK3R5		IGH	possible rearrangement		FISH	
TH03_0013_S01	acute lymphoblastic leukemia	RNA only target	RNA only target	leukemia						new sample				
					No druggable mutations		Cell cycle	CDK6						
							PI3K/AKT/mTOR	PIK3CD						
							PI3K/AKT/mTOR	PIK3R5		IGH	possible rearrangement		FISH	
TH03_0014_S01	sarcoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		JAK/STAT		JAK1	EWSR1	EWSR1-FL1 rearrangement		Foundation Medicine	
										FLI1 	EWSR1-FL1 rearrangement		Foundation Medicine	
TH03_0018_S01	sarcoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		Receptor Tyrosine Kinase (RTK)	FLT4		EWSR1	negative for rearrangement		Foundation Medicine	
										SS18	negative for rearrangement		Foundation Medicine	
										FM performed, no alterations identified	none		Foundation Medicine	
TH03_0020_S01	medulloblastoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		Sonic Hedgehog (SHH)	PTCH1		MYC	High amplification		"per EPIC" in clinical notes	
TH03_0112_S01	sarcoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		Receptor Tyrosine Kinase (RTK)	ERBB2		SS18	SS18-SSX translocation		Foundation Medicine	
							PI3K/AKT/mTOR	MLST8		SSX	SS18-SSX translocation		Foundation Medicine	
TH03_0112_S02	sarcoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		Sonic Hedgehog (SHH)	GLI1		SS18	SS18-SSX translocation		Foundation Medicine	
							Sonic Hedgehog (SHH)	PTCH1		SSX	SS18-SSX translocation		Foundation Medicine	
TH03_0113_S01	myoepithelial carcinoma of the liver	No	Additional expression support for DNA finding	solid						new sample				
					INI1 loss of expression	Chromating remodeling	Receptor Tyrosine Kinase (RTK)	FGFR1		INI1	Loss of expression		IHC	
TH03_0115_S01	teratoma	No DNA or RNA targets	No DNA or RNA targets	solid						new sample				
					No druggable mutations		No automated leads			MLL3	C310S		Foundation Medicine	
TH03_0141_S01	osteosarcoma	Yes	Prioritizing among multiple DNA findings	solid						new sample				
					CCND3 amplification	Cell Cycle	Cell cycle	CCND3		CSK4	Amplification		probably Foundation Medicine	
							Cell cycle	CDK4		MDM2	Amplification		probably Foundation Medicine	
					MDM2 amplification	BCL2/MDM2	BCL2/MDM2	MDM2		CCND3	Amplification		probably Foundation Medicine	
										FRS2	Amplification		probably Foundation Medicine	
TH03_0144_S01	wilms tumor	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		PI3K/AKT/mTOR	MLST8						
							JAK/STAT	STAT1		FM performed, no alterations identified	none		Foundation Medicine	
TH03_0146_S01	sarcoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		Cell cycle		CCNE1	CIC	CIC-DUX4 translocation		part of diagnostic term	
							Receptor Tyrosine Kinase (RTK)		FLT4	DUX4	CIC-DUX4 translocation		part of diagnostic term	
TH03_0296_S01	osteosarcoma	No DNA or RNA targets	No DNA or RNA targets	solid						new sample				
					No druggable mutations		No automated leads			MSH3	Splice site 580-2a>g		Foundation Medicine	
TH03_0296_S02	osteosarcoma	RNA only target	RNA only target	solid						new sample				
					No druggable mutations		Receptor Tyrosine Kinase (RTK)		TEK	MSH3	Splice site 580-2a>g		Foundation Medicine	
TH06_0645_S01	sarcoma	No	Additional expression support for DNA finding	solid						new sample				
					NF1 stop gained	RAS/RAF/MEK				NF1	stop gained		BC POG DNA results	
							Receptor Tyrosine Kinase (RTK)	EGFR		POTEI	missense (benign/tolerated)		BC POG DNA results	
							Receptor Tyrosine Kinase (RTK)	ERBB3		MUC17	missense		BC POG DNA results	
							Sonic Hedgehog (SHH)	PTCH1		HERC2	deletion/frame shift		BC POG DNA results	
										NOTCH2	deletion frame shift		BC POG DNA results	
										NCOA3	two codon deletion		BC POG DNA results	
										MARCKS	fusion with HERC2		BC POG DNA results	
										HERC2	fusion with MARCKS		BC POG DNA results	
										ASH1L	65 aa insertion		BC POG DNA results	
TH06_0646_S01	neurofibroma	No	Additional expression support for DNA finding	solid						new sample				
					NF1 loss	RAS/RAF/MEK				NF1	loss		BC POG DNA results	
							Receptor Tyrosine Kinase (RTK)		ERBB3	ACSM5	D400N		BC POG DNA results	
							Sonic Hedgehog (SHH)		PTCH1	PRSS3	R255G		BC POG DNA results	
										PDE4DIP inversion	inversion		BC POG DNA results	
										SSH2	loss		BC POG DNA results	
TH06_0647_S01	diffuse intrinsic pontine glioma	Yes	Prioritizing among multiple DNA findings	solid						new sample				
										GSX2	amplification		BC POG DNA results	
					KDR amplification	Receptor Tyrosine Kinase (RTK)				KDR	amplification		BC POG DNA results	
					PDGFRA amplification	Receptor Tyrosine Kinase (RTK)	Receptor Tyrosine Kinase (RTK)		PDGFRA, PDGFRB	PDGFRA	amplification		BC POG DNA results	
										BET1L	homozygous loss		BC POG DNA results	
										ELOA3	homozygous loss		BC POG DNA results	
										GRID1	homozygous loss		BC POG DNA results	
										MYO5B	homozygous loss		BC POG DNA results	
										PTPN13	homozygous loss		BC POG DNA results	
										PTPN14	gain		BC POG DNA results	
										HRNR	missense (present in normal)		BC POG DNA results	
										H3F3A	missense		BC POG DNA results	
										RYR2	missense		BC POG DNA results	
										POMP	missense		BC POG DNA results	
										TP53	copy loss		BC POG DNA results	
										GOLGA6L2	missense		BC POG DNA results	
										TP53	missense		BC POG DNA results	
										KRTAP2-2	missense		BC POG DNA results	
										SCN4A	missense		BC POG DNA results	
										MAST3	missense		BC POG DNA results	
										TDRD12	missense		BC POG DNA results	
										TDRD12	missense		BC POG DNA results	
										UBE2F	missense		BC POG DNA results	
										MUC4	missense		BC POG DNA results	
										TMEM165	missense		BC POG DNA results	
										KHDRBS2	missense		BC POG DNA results	
TH06_0648_S01	acute lymphoblastic leukemia	Yes	Prioritizing among multiple DNA findings	leukemia						new sample				
										IGHJ6	translocation		BC POG DNA results	
										IGHM	translocation		BC POG DNA results	
										KLF9	translocation		BC POG DNA results	
										NCOR1	translocation		BC POG DNA results	
										NUP160	translocation		BC POG DNA results	
										SLC29A1	translocation		BC POG DNA results	
										SUZ12	translocation		BC POG DNA results	
										ZBTB44	translocation		BC POG DNA results	
										ZCCHC7	translocation		BC POG DNA results	
										ETV6	deletion/duplication		BC POG DNA results	
					CDKN2A homozygous loss	Cell Cycle	Cell cycle	CCND3, CDK6		CDKN2A	homozygous loss		BC POG DNA results	
										CNR2	homozygous loss		BC POG DNA results	
										CNTNAP3B	homozygous loss		BC POG DNA results	
										DMRTA1	homozygous loss		BC POG DNA results	
										MTAP	homozygous loss		BC POG DNA results	
										PGBD4P5	homozygous loss		BC POG DNA results	
										PNRC2	homozygous loss		BC POG DNA results	
										RBM17P3	homozygous loss		BC POG DNA results	
										TJP2	homozygous loss		BC POG DNA results	
										FLT3	T227M		BC POG DNA results	
					RAS p.G12A	RAS/RAF/MEK				RAS	G12A		BC POG DNA results	
					RAS p.G13D	RAS/RAF/MEK				RAS	G13D		BC POG DNA results	
										PCNT	R3232L		BC POG DNA results	
										PCNT	R3232R		BC POG DNA results	
										NTRK3	Q185K		BC POG DNA results	
										KIT V48L	V48L – not characterized		BC POG DNA results	
										ZNF521	V574I		BC POG DNA results	
										IGF1R	Y203F		BC POG DNA results	
							B-cell receptor signaling	BTK					BC POG DNA results	
							Receptor Tyrosine Kinase (RTK)	FLT3					BC POG DNA results	
TH06_0649_S01	neuroblastoma	Yes	Prioritizing among multiple DNA findings	solid						new sample				
										CST3	duplication		BC POG DNA results	
					RPTOR amplification	PI3K/AKT/mTOR	PI3K/AKT/mTOR		RPTOR	RPTOR	allele-specific copy number amplifications		BC POG DNA results	